Refractory Hematologic Malignancy

Explore clinical trials studying Refractory Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

5 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Refractory Hematologic Malignancy trial results

Recruiting

NCT04515810

Conditions: Death, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Northwell Health Manhasset, New York, United States

Mount Sinai Hospital New York, United States

NYP/Weill Cornell Medical Center New York, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Recruiting

NCT05713214

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +4 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

Recruiting

NCT03328078

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +17 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

Mayo Clinic Phoenix, Arizona, United States

City of Hope Duarte, California, United States

Providence St. John's Health Center Santa Monica, California, United States

View all 45 locations

Recruiting

NCT05270096

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +6 more
Locations: UH Gent Ghent, Belgium

Righospitalet Copenhagen, Denmark

Semmelweis Budapest, Hungary

Princess Máxima Center for Pediatric Oncology Utrecht, Netherlands

Completed

NCT04681105

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
Locations: City of Hope Medical Center Duarte, California, United States